Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer

por Zoli, W, Ricotti, L, Susino, M Dal, Barzanti, F, Frassineti, G L, Folli, S, Tesei, A, Bacci, F, Amadori, D
Publicado 1999

Activity of endovesical gemcitabine in BCG-refractory bladder cancer patients: a translational study

por Gunelli, R, Bercovich, E, Nanni, O, Ballardini, M, Frassineti, G L, Giovannini, N, Fiori, M, Pasquini, E, Ulivi, P, Pappagallo, G L, Silvestrini, R, Zoli, W
Publicado 2007

Role of biological markers in the clinical outcome of colon cancer

por Nanni, O, Volpi, A, Frassineti, G L, De Paola, F, Granato, A M, Dubini, A, Zoli, W, Scarpi, E, Turci, D, Oliverio, G, Gambi, A, Amadori, D
Publicado 2002

New Biomarkers to Predict the Evolution of In Situ Breast Cancers

por Bravaccini, S., Tumedei, M. M., Scarpi, E., Zoli, W., Rengucci, C., Serra, L., Curcio, A., Buggi, F., Folli, S., Rocca, A., Maltoni, R., Puccetti, M., Amadori, D., Silvestrini, R.
Publicado 2014